Expand Document  |  Expand Chapter  |  Full TOC  |  Printable HTML version
WHO Expert Committee on Specifications for Pharmaceutical Preparations - WHO Technical Report Series, No. 885 - Thirty-fifth Report
(1999; 168 pages) [Spanish] View the PDF document
Table of Contents
View the documentWHO Expert Committee on Specifications for Pharmaceutical Preparations
View the document1. Introduction
Open this folder and view contents2. The international pharmacopoeia and related issues
Open this folder and view contents3. International Chemical Reference Substances and Infrared Reference Spectra
Open this folder and view contents4. Quality control - national laboratories
Open this folder and view contents5. Good manufacturing practices
Open this folder and view contents6. Quality systems and inspection
Open this folder and view contents7. Other quality assurance topics
Open this folder and view contents8. Nomenclature and terminology
Open this folder and view contents9. Legal aspects of pharmaceuticals
Open this folder and view contents10. Regulatory issues
Open this folder and view contents11. Training activities
View the document12. Pharmaceuticals contaminated with diethylene glycol
View the documentAcknowledgements
View the documentReferences
View the documentAnnex 1. List of available International Chemical Reference Substances1
View the documentAnnex 2. List of available International Infrared Reference Spectra1
Open this folder and view contentsAnnex 3. General guidelines for the establishment, maintenance and distribution of chemical reference substances
Open this folder and view contentsAnnex 4. Good manufacturing practices: authorized person - role, functions and training
Open this folder and view contentsAnnex 5. Good manufacturing practices: supplementary guidelines for the manufacture of pharmaceutical excipients
Open this folder and view contentsAnnex 6. Guidelines for inspection of drug distribution channels
View the documentAnnex 7. Good pharmacy practice in community and hospital pharmacy settings
Open this folder and view contentsAnnex 8. National drug regulatory legislation: guiding principles for small drug regulatory authorities
Open this folder and view contentsAnnex 9. Provisional guidelines for developing training programmes: inspection and examination of counterfeit pharmaceuticals
View the documentWorld Health Organization Technical Report Series
View the documentSelected WHO Publications of Related Interest
View the documentBack Cover
 

Selected WHO Publications of Related Interest

 

Price (Sw. fr.)*

The international pharmacopoeia, third edition

 

Volume 1: general methods of analysis. 1979 (223 pages)

24.-

Volume 2: quality specifications. 1981 (342 pages)

36.-

Volume 3: quality specifications. 1988 (407 pages)

64.-

Volume 4: tests, methods, and general requirements; quality specifications for pharmaceutical substances, excipients, and dosage forms. 1994 (358 pages)

85.-

Basic tests for drugs: pharmaceutical substances, medicinal plant materials and dosage forms.
1998 (hi + 91 pages)

26.-

Basic tests for pharmaceutical dosage forms.
1991 (v + 129 pages)

24.-

Basic tests for pharmaceutical substances.
1986 (205 pages)

34.-

Quality assurance of pharmaceuticals: a compendium of guidelines and related materials, Vol. 1.
1997 (vi + 238 pages)

50.-

Quality control methods for medicinal plant materials.
1998 (viii + 115 pages)

35.-

WHO Expert Committee on Specifications for Pharmaceutical Preparations.
Thirty-fourth report.
WHO Technical Report Series, No. 863, 1996 (vi + 194 pages)

35.-

International nonproprietary names (INN) for pharmaceutical substances. Cumulative list no. 9.
1996 (xiii + 885 pages)

250.-

The use of essential drugs.
Eighth report of the WHO Expert Committee (including the revised Model List of Essential Drugs)
WHO Technical Report Series, No. 882, 1998 (vi + 77 pages)

19.-

WHO Expert Committee on Biological Standardization.
Forty-seventh report.
WHO Technical Report Series, No. 878, 1998 (vi + 101 pages)

20.-

* Prices in developing countries ore 70% of those listed here.

Further information on these and other WHO publications can be obtained from Marketing and Dissemination, World Health Organization, 1211 Geneva 27, Switzerland

 

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: November 5, 2014